Cg Oncology Inc’s filing revealed that its Director Mulay James unloaded Company’s shares for reported $0.26 million on Oct 09 ’25. In the deal valued at $43.99 per share,5,903 shares were sold. As a result of this transaction, Mulay James now holds 0 shares worth roughly $0.0.
Then, JAMES MULAY bought 6,557 shares, generating $266,935 in total proceeds.
Before that, POST LEONARD E sold 5,000 shares. Cg Oncology Inc shares valued at $200,450 were divested by the Director at a price of $40.09 per share. As a result of the transaction, POST LEONARD E now holds 0 shares, worth roughly $0.0.
Guggenheim initiated its Cg Oncology Inc [CGON] rating to a Buy in a research note published on October 08, 2025; the price target was $90. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. JP Morgan started covering the stock on May 02, 2025. It rated CGON as “an Overweight”.
Price Performance Review of CGON
On Friday, Cg Oncology Inc [NASDAQ:CGON] saw its stock fall -2.72% to $43.25. Over the last five days, the stock has gained 8.61%. Cg Oncology Inc shares have risen nearly 24.21% since the year began. Nevertheless, the stocks have risen 50.80% over the past one year.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-09-30, growing by 1.76 million shares to a total of 11.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 10.23 million shares. There was a rise of 14.67%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 16, 2025 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $23 price target.
